{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:43:02Z","timestamp":1790764982461,"version":"4.1.0"},"reference-count":26,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,1,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Women treated at young ages with supradiaphragmatic radiotherapy for Hodgkin lymphoma (HL) have a highly increased risk of breast cancer. For personalized advice and follow-up regimens for patients, information is needed on how the radiotherapy-related risk is affected by other breast cancer risk factors. Genome-wide association studies have identified 14 independently replicated common single nucleotide polymorphisms that influence breast cancer risk. To examine whether these variants contribute to risk of radiation-associated breast cancer in HL, we analyzed 2 independent case-control series, from the United Kingdom and The Netherlands, totaling 693 HL patients, 232 with breast cancer and 461 without. rs1219648, which annotates the FGFR2 gene, was associated with risk in both series (combined per-allele odds ratio = 1.59, 95% confidence interval: 1.26-2.02; P = .000111). These data provide evidence that genetic variation in FGFR2 influences radiation-induced breast cancer risk.<\/jats:p>","DOI":"10.1182\/blood-2011-10-383380","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T07:08:55Z","timestamp":1323155335000},"page":"1029-1031","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":30,"title":["FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma"],"prefix":"10.1182","volume":"119","author":[{"given":"Yussanne P.","family":"Ma","sequence":"first","affiliation":[{"name":"Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora E.","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Netherlands Cancer Institute\u2013Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Cooke","sequence":"additional","affiliation":[{"name":"Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegien","family":"Broeks","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapy, Netherlands Cancer Institute\u2013Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Enciso-Mora","sequence":"additional","affiliation":[{"name":"Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Olver","sequence":"additional","affiliation":[{"name":"Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Broderick","sequence":"additional","affiliation":[{"name":"Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola S.","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Netherlands Cancer Institute\u2013Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Janus","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center, Daniel den Hoed, Rotterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Ashworth","sequence":"additional","affiliation":[{"name":"The Breakthrough Breast Cancer Research Centre, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Houlston","sequence":"additional","affiliation":[{"name":"Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111807274135000_B1","first-page":"347","article-title":"Second cancers after treatment of Hodgkin lymphoma.","volume-title":"Hodgkin Lymphoma","author":"van Leeuwen","year":"2007"},{"key":"2019111807274135000_B2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-3-642-12780-9_22","article-title":"Second malignancy risk after treatment of Hodgkin lymphoma.","volume-title":"Hodgkin Lymphoma","author":"Hodgson","year":"2011"},{"issue":"26","key":"2019111807274135000_B3","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111807274135000_B4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/02841860152619115","article-title":"The inherited basis of human radiosensitivity.","volume":"40","author":"Gatti","year":"2001","journal-title":"Acta Oncol"},{"issue":"12","key":"2019111807274135000_B5","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/09553000050201109","article-title":"Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay.","volume":"76","author":"Burrill","year":"2000","journal-title":"Int J Radiat Biol"},{"issue":"5","key":"2019111807274135000_B6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.353","article-title":"A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).","volume":"41","author":"Thomas","year":"2009","journal-title":"Nat Genet"},{"issue":"7","key":"2019111807274135000_B7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ng2064","article-title":"Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.","volume":"39","author":"Stacey","year":"2007","journal-title":"Nat Genet"},{"issue":"5","key":"2019111807274135000_B8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng.354","article-title":"Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.","volume":"41","author":"Ahmed","year":"2009","journal-title":"Nat Genet"},{"issue":"7148","key":"2019111807274135000_B9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","article-title":"Genome-wide association study identifies novel breast cancer susceptibility loci.","volume":"447","author":"Easton","year":"2007","journal-title":"Nature"},{"issue":"5","key":"2019111807274135000_B10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/djq563","article-title":"Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.","volume":"103","author":"Fletcher","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2019111807274135000_B11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.131","article-title":"Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.","volume":"40","author":"Stacey","year":"2008","journal-title":"Nat Genet"},{"issue":"11","key":"2019111807274135000_B12","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1073\/pnas.0800441105","article-title":"Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.","volume":"105","author":"Gold","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111807274135000_B13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng.318","article-title":"Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.","volume":"41","author":"Zheng","year":"2009","journal-title":"Nat Genet"},{"issue":"12","key":"2019111807274135000_B14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ng.696","article-title":"A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).","volume":"42","author":"Enciso-Mora","year":"2010","journal-title":"Nat Genet"},{"issue":"14","key":"2019111807274135000_B15","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/onc.2009.489","article-title":"Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.","volume":"29","author":"Turner","year":"2010","journal-title":"Oncogene"},{"issue":"11","key":"2019111807274135000_B16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1158\/1541-7786.MCR-10-0168","article-title":"Roles of fibroblast growth factor receptors in carcinogenesis.","volume":"8","author":"Haugsten","year":"2010","journal-title":"Mol Cancer Res"},{"issue":"5","key":"2019111807274135000_B17","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1371\/journal.pbio.0060108","article-title":"Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.","volume":"6","author":"Meyer","year":"2008","journal-title":"PLoS Biol"},{"issue":"4B","key":"2019111807274135000_B18","first-page":"2141","article-title":"Restoration of FGF receptor type 2 enhances radiosensitivity of hormone-refractory human prostate carcinoma PC-3 cells.","volume":"28","author":"Matsubara","year":"2008","journal-title":"Anticancer Res"},{"issue":"8","key":"2019111807274135000_B19","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2002.08.031","article-title":"Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study.","volume":"20","author":"Diller","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111807274135000_B20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.bjc.6605215","article-title":"The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.","volume":"101","author":"Howell","year":"2009","journal-title":"Br J Cancer"},{"issue":"9015","key":"2019111807274135000_B21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(96)91114-9","article-title":"Breast cancer and radiotherapy in ataxia-telangiectasia heterozygote.","volume":"347","author":"Ramsey","year":"1996","journal-title":"Lancet"},{"issue":"12","key":"2019111807274135000_B22","first-page":"3813","article-title":"Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.","volume":"8","author":"Offit","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2019111807274135000_B23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/095530000138367","article-title":"Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.","volume":"76","author":"Broeks","year":"2000","journal-title":"Int J Radiat Biol"},{"issue":"9081","key":"2019111807274135000_B24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0140-6736(05)62074-0","article-title":"Family history of patients with breast cancer after treatment of Hodgkin's disease in childhood.","volume":"350","author":"Late Effects Study Group","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"2019111807274135000_B25","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2005-04-1535","article-title":"Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.","volume":"106","author":"Hill","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111807274135000_B26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2009.07946.x","article-title":"IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma.","volume":"148","author":"Broderick","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/4\/1029\/1354361\/zh800412001029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/4\/1029\/1354361\/zh800412001029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T12:35:18Z","timestamp":1574080518000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/4\/1029\/29676\/FGFR2-genotype-and-risk-of-radiationassociated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,1,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-383380","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}